申请人:Moir Donald T.
公开号:US20140142134A1
公开(公告)日:2014-05-22
Organic compounds showing the ability to inhibit effector toxin secretion or translocation mediated by bacterial type III secretion systems are disclosed. The disclosed type III secretion system inhibitor compounds are useful for combating infections by Gram-negative bacteria such as
Salmonella
spp.,
Shigella flexneri, Psendomonas
spp.,
Yersinia
spp., en tero pathogenic and enteroinvasive
Escherichia
coli, and
Chlamydia
spp. having such type III secretion systems.